These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 31834085)

  • 1. Trends in the Use of Long-Acting Injectable Antipsychotics in the Province of Manitoba, Canada.
    Janzen D; Bolton J; Kuo IF; Leong C; Alessi-Severini S
    J Clin Psychopharmacol; 2020; 40(1):6-13. PubMed ID: 31834085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Concurrent Oral and Long-Acting Injectable Antipsychotic Prescribing at the Minneapolis Veterans Affairs Health Care System.
    Dimitropoulos E; Drogemuller L; Wong K
    J Clin Psychopharmacol; 2017 Oct; 37(5):605-608. PubMed ID: 28816923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors for starting depot administration of risperidone in chronic users of antipsychotics.
    Vehof J; Postma MJ; Bruggeman R; De Jong-Van Den Berg LT; Van Den Berg PB; Stolk RP; Burger H
    J Clin Psychopharmacol; 2008 Dec; 28(6):625-30. PubMed ID: 19011430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative effectiveness of long-acting injectable risperidone vs. long-acting injectable first-generation antipsychotics in bipolar disorder.
    Wu CS; Hsieh MH; Tang CH; Chang CJ
    J Affect Disord; 2016 Jun; 197():189-95. PubMed ID: 26994437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utilization and costs of antipsychotic agents: a Canadian population-based study, 1996-2006.
    Alessi-Severini S; Biscontri RG; Collins DM; Kozyrskyj A; Sareen J; Enns MW
    Psychiatr Serv; 2008 May; 59(5):547-53. PubMed ID: 18451015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "Impact of drug-reimbursement policies on prescribing: A case-study of a newly marketed long-acting injectable antipsychotic among relapsed schizophrenia patients".
    Jackson JW; Fulchino L; Rogers J; Mogun H; Polinski J; Henderson DC; Schneeweiss S; Fischer MA
    Pharmacoepidemiol Drug Saf; 2018 Jan; 27(1):95-104. PubMed ID: 29168261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-acting injectable antipsychotics for the treatment of schizophrenia in Spain.
    Arango C; Baeza I; Bernardo M; Cañas F; de Dios C; Díaz-Marsá M; García-Portilla MP; Gutiérrez-Rojas L; Olivares JM; Rico-Villademoros F; Rodríguez-Jiménez R; Sánchez-Morla EM; Segarra R; Crespo-Facorro B
    Rev Psiquiatr Salud Ment (Engl Ed); 2019; 12(2):92-105. PubMed ID: 29954707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antipsychotic Medication Prescribing Trends in a Pediatric Population in Northern Poland 2008-2012.
    Waszak PM; Zagożdżon P; Pierucka M; Kubanek A
    J Child Adolesc Psychopharmacol; 2018 Nov; 28(9):631-636. PubMed ID: 30048153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].
    Llorca PM; Miadi-Fargier H; Lançon C; Jasso Mosqueda G; Casadebaig F; Philippe A; Guillon P; Mehnert A; Omnès LF; Chicoye A; Durand-Zaleski I
    Encephale; 2005; 31(2):235-46. PubMed ID: 15959450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antipsychotic long-acting injections: A community-based study from 2007 to 2014 of prescribing trends and characteristics associated with initiation.
    Verdoux H; Pambrun E; Tournier M; Bezin J; Pariente A
    Schizophr Res; 2016 Dec; 178(1-3):58-63. PubMed ID: 27624680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment Patterns, Health Care Resource Utilization, and Spending in Medicaid Beneficiaries Initiating Second-generation Long-acting Injectable Agents Versus Oral Atypical Antipsychotics.
    Pilon D; Tandon N; Lafeuille MH; Kamstra R; Emond B; Lefebvre P; Joshi K
    Clin Ther; 2017 Oct; 39(10):1972-1985.e2. PubMed ID: 28919292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ten years of antipsychotic prescribing to children: a Canadian population-based study.
    Alessi-Severini S; Biscontri RG; Collins DM; Sareen J; Enns MW
    Can J Psychiatry; 2012 Jan; 57(1):52-8. PubMed ID: 22296959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prescribing trends of antipsychotics in youth receiving income assistance: results from a retrospective population database study.
    Murphy AL; Gardner DM; Cooke C; Kisely S; Hughes J; Kutcher SP
    BMC Psychiatry; 2013 Jul; 13():198. PubMed ID: 23890157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-acting injectable risperidone for the treatment of schizophrenia: clinical perspectives.
    Möller HJ
    Drugs; 2007; 67(11):1541-66. PubMed ID: 17661527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attitudes of Croatian psychiatrists towards long-acting injectable antipsychotics.
    Ciglar M; Bjedov S; Maleković H
    Psychiatr Danub; 2016 Sep; 28(3):273-277. PubMed ID: 27658836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
    Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
    Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Explicit review of risperidone long-acting injection prescribing practice.
    Wheeler A; Vanderpyl J; Carswell C; Stojkovic M; Robinson E
    J Clin Pharm Ther; 2011 Dec; 36(6):651-63. PubMed ID: 22023342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of initiating long-acting injectable antipsychotics on hospitalization in patients with bipolar I disorder.
    Yan T; Greene M; Chang E; Touya M; Broder MS
    J Comp Eff Res; 2018 Nov; 7(11):1083-1093. PubMed ID: 30129771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of Prescribing Patterns of Long-Acting Injectable Antipsychotics Within a Community Health System.
    Netley J; Gaul J; Ferguson C
    J Clin Psychopharmacol; 2019; 39(5):494-498. PubMed ID: 31425464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. National changes in oral antipsychotic treatment for people with schizophrenia in primary care between 1998 and 2007 in the United Kingdom.
    Prah P; Petersen I; Nazareth I; Walters K; Osborn D
    Pharmacoepidemiol Drug Saf; 2012 Feb; 21(2):161-9. PubMed ID: 21858898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.